David W. Dube
Präsident bei Stock Car Stocks Mutual Fund, Inc.
Aktive Positionen von David W. Dube
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Stock Car Stocks Mutual Fund, Inc. | Präsident | 23.12.2009 | - |
Karriereverlauf von David W. Dube
Ehemalige bekannte Positionen von David W. Dube
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CNE Group, Inc. | Direktor/Vorstandsmitglied | - | 14.11.2005 |
| SWAN GROUP OF COMPANIES, INC. | Vorsitzender | - | - |
| Finanzdirektor/CFO | - | - | |
Glycogenesys, Inc.
 Glycogenesys, Inc. Miscellaneous Commercial ServicesCommercial Services GlycoGenesys, Inc., a biotechnology company, develops novel pharmaceutical products based on carbohydrate compounds and related technologies. The company's lead drug candidate GCS-100, a treatment for various forms of solid tumors and bloodborne cancers, completed a Phase II (a) clinical trial for pancreatic cancer, and also completed a Phase II (a) clinical trial for colorectal cancer. The company focuses on the development of carbohydrate-based pharmaceutical products and related technologies in connection with oncology. It was founded in 1992 and is headquartered in Boston, MA. | Direktor/Vorstandsmitglied | 01.05.1998 | - |
| Independent Dir/Board Member | 01.05.1998 | - |
Ausbildung von David W. Dube
| Suffolk University | Graduate Degree |
| Bentley University | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Director/Board Member | 2 |
| Graduate Degree | 2 |
| Independent Dir/Board Member | 1 |
Sektoral
| Commercial Services | 3 |
| Consumer Services | 3 |
| Miscellaneous | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
| CNE Group, Inc. | Commercial Services |
Glycogenesys, Inc.
Glycogenesys, Inc. Miscellaneous Commercial ServicesCommercial Services GlycoGenesys, Inc., a biotechnology company, develops novel pharmaceutical products based on carbohydrate compounds and related technologies. The company's lead drug candidate GCS-100, a treatment for various forms of solid tumors and bloodborne cancers, completed a Phase II (a) clinical trial for pancreatic cancer, and also completed a Phase II (a) clinical trial for colorectal cancer. The company focuses on the development of carbohydrate-based pharmaceutical products and related technologies in connection with oncology. It was founded in 1992 and is headquartered in Boston, MA. | Commercial Services |
| Stock Car Stocks Mutual Fund, Inc. | Miscellaneous |
Swan Group of Cos., Inc.
 Swan Group of Cos., Inc. Wholesale DistributorsDistribution Services Swan Group of Companies, Inc. engages in the manufacture and sale of smokeless cigarette products. The company was founded on January 24, 1996 and is headquartered in Largo, FL. | Distribution Services |
- Börse
- Insiders
- David W. Dube
- Erfahrung
